Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ACRX

AcelRx Pharmaceuticals (ACRX) Stock Price, News & Analysis

AcelRx Pharmaceuticals logo

About AcelRx Pharmaceuticals Stock (NASDAQ:ACRX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.49
$0.86
52-Week Range
N/A
Volume
243,500 shs
Average Volume
137,683 shs
Market Capitalization
$14.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ACRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AcelRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ACRX Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
See More Headlines

ACRX Stock Analysis - Frequently Asked Questions

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) posted its quarterly earnings data on Monday, November, 15th. The specialty pharmaceutical company reported ($1.40) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($1.40). The specialty pharmaceutical company earned $1.86 million during the quarter, compared to the consensus estimate of $1.20 million.

Shares of AcelRx Pharmaceuticals reverse split before market open on Wednesday, October 26th 2022.The 1-20 reverse split was announced on Wednesday, October 26th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, October 26th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that AcelRx Pharmaceuticals investors own include Advanced Micro Devices (AMD), Novavax (NVAX), Amarin (AMRN), Amicus Therapeutics (FOLD), Inovio Pharmaceuticals (INO), Meta Platforms (META) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
11/15/2021
Today
7/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ACRX
Employees
19
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$47.76 million
Pretax Margin
-3,711.25%

Debt

Sales & Book Value

Annual Sales
$1.77 million
Price / Cash Flow
N/A
Book Value
$2.65 per share
Price / Book
N/A

Miscellaneous

Free Float
16,443,000
Market Cap
$14.58 million
Optionable
Optionable
Beta
0.52

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:ACRX) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners